As a scientist I perform molecular biological and histotechnological research on the structure and function of conventional (e.g., right-handed B-DNA), alternative (e.g., Z-DNA) and multi-stranded (e.g., triplex DNA) DNA and RNA molecules, in both normal and diseased tissue [e.g., eye (ocular lens) (cataracts), and skin (epidermis) (e.g., melanoma, Xeroderma Pigmentosum)].
As a nucleic acid nanotechnologist, I develop the next generation of DNA and RNA microarrays [i.e., Novel multistranded and alternative DNA, RNA and plasmid microarrays (transitional structural nucleic acid microarrays)]. This involves new ways of immobilizing intact, non-denatured unaltered nucleic acids to enhanced substrate surfaces. In addition I am also involved in developing techniques that can be used with the novel microarrays, viz., original genomic and proteomic techniques/methods (i.e., transitional structural chemogenomics, transitional structural chemoproteomics, transitional structural pharmacogenomics, transitional structural pharmacoproteomics).
Furthermore, I develop novel approaches to fixing tissues for superior histotechnological processing of preserved DNA, RNA and nucleic acid-protein complexes in tissues. These tissues can then be better characterized immunohistochemically and histochemically for the presence of nucleic acids. Presently, I am trying to manufacture the novel microarrays using standard industry equipment and locating companies interested in licensing the Gagna/NYIT patent (i.e., Method for immobilizing multistranded nucleic acid molecules by modifying more than one strand thereof, and binding each strand to a solid support: August 30, 2005 - 6,936,461).